Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Antonio Webb

Orthopaedic Surgery of the Spine San Antonio, TX Medical Doctor

NPI 1003226440 CMS profile 5702614

9150 Huebner Rd Ste 290, San Antonio, TX 78240

Open in the dashboard

General payments

$75,048

193 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Antonio Webb of San Antonio, TX is reported in the CMS Open Payments database as having received $75,048 across 193 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,965 15
2024 General $8,512 13
2023 General $17,490 28
2022 General $21,458 31
2021 General $5,140 49
2020 General $5,297 25
2019 General $12,186 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Antonio Webb
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Antonio Webb were reported at $4,965. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Antonio Webb Orthopaedic Surgery of the Spine median Middle half National median
2019 $12,186 $2,106 $337–$18,608 $163
2020 $5,297 $1,213 $156–$15,082 $114
2021 $5,140 $1,834 $271–$15,617 $132
2022 $21,458 $2,015 $320–$17,036 $149
2023 $17,490 $1,925 $336–$14,599 $160
2024 $8,512 $2,110 $341–$12,483 $164
2025 $4,965 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DeGen Medical, Inc. $47,589 35 payments
  2. NuVasive, Inc. $10,000 14 payments
  3. Globus Medical, Inc. $3,354 11 payments
  4. Spine Wave, Inc. $3,000 3 payments
  5. SI-BONE, Inc. $2,078 34 payments
  6. Stryker Corporation $1,380 11 payments
  7. Medical Device Business Services, Inc. $1,368 9 payments
  8. Alphatec Spine, Inc $1,147 6 payments
  9. Curiteva, Inc. $1,031 3 payments
  10. Medtronic USA, Inc. $861 6 payments
  11. Other $3,240 61 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $31,265 34 payments
  2. Consulting Fee $25,355 11 payments
  3. Food and Beverage $10,428 147 payments
  4. Grant $8,000 1 payment
Products named General payments · program years 2019–2025
  1. XR $18,055 5 payments
  2. SI SCREW $3,300 2 payments
  3. EXCELSIUS GPS Spine/Joint $1,462 9 payments
  4. IFUSE IMPLANT $1,446 22 payments
  5. EXPEDIUM $1,390 10 payments
  6. ALTERA $1,037 1 payment
  7. Other - Miscellaneous $1,036 3 payments
  8. EXCELSIUS GPS Spine/Spine Surgery $855 1 payment
  9. AVIATOR $605 4 payments
  10. XLIF $562 6 payments
  11. Other $5,986 92 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

909

Median for Orthopedic Surgery: 203

Drug cost

$6,571

Median for Orthopedic Surgery: $1,433

Branded share of claims

12.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tizanidine Hcl Generic 137 $2,020
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 111 $1,657
Meloxicam Generic 451 $1,078
Methylprednisolone Generic 113 $985
Gabapentin Generic 31 $299
Celecoxib Generic 19 $275
Tramadol Hcl Generic 30 $136
Methocarbamol Generic 17 $121

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$138,750

Medicare's payments for the services billed

Medicare patients

344

Average age 72

Services billed

1,351

195 women, 149 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Ischemic heart disease 32%
Chronic kidney disease 25%
Osteoporosis 25%
Depression 23%
COPD 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

193 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record